Literature DB >> 778616

The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy.

L H Miller, S J Mason, D F Clyde, M H McGinniss.   

Abstract

Duffy-blood-group-negative human erythrocytes, FyFy, are resistant to invasion in vitro by Plasmodium knowlesi. The FyFy genotype is found predominantly in African and American blacks, who are the only groups completely resistant to infection by P. vivax. To determine if the FyFy genotype is the vivax resistance factor, we performed blood typing on 11 black and six white volunteers who had been exposed to the bites of P. vivax-infected mosquitoes. Only the five FyFy blacks were resistant to erythrocytic infection; the remaining six blacks and all whites had the Duffy-positive determinants (Fya or Fyb or both) and had contracted malaria. We conclude that Duffy determinants (Fya or Fyb or both) on the erythrocyte surface are required for invasion of erythrocytes by vivax merozoites.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 778616     DOI: 10.1056/NEJM197608052950602

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  393 in total

1.  Detection of the signature of natural selection in humans: evidence from the Duffy blood group locus.

Authors:  M T Hamblin; A Di Rienzo
Journal:  Am J Hum Genet       Date:  2000-04-12       Impact factor: 11.025

2.  Significant admixture linkage disequilibrium across 30 cM around the FY locus in African Americans.

Authors:  J A Lautenberger; J C Stephens; S J O'Brien; M W Smith
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

Review 3.  Science, medicine, and the future: susceptibility to infection.

Authors:  D Kwiatkowski
Journal:  BMJ       Date:  2000-10-28

4.  A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.

Authors:  Dorota Smolarek; Claude Hattab; Gholamreza Hassanzadeh-Ghassabeh; Sylvie Cochet; Carlos Gutiérrez; Alexandre G de Brevern; Rachanee Udomsangpetch; Julien Picot; Magdalena Grodecka; Kazimiera Wasniowska; Serge Muyldermans; Yves Colin; Caroline Le Van Kim; Marcin Czerwinski; Olivier Bertrand
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

5.  Sensitivity of Plasmodium vivax to chloroquine, mefloquine, artemisinin and atovaquone in north-western Thailand.

Authors:  Moritz Treiber; Gunther Wernsdorfer; Ursula Wiedermann; Kanungnit Congpuong; Jeeraphat Sirichaisinthop; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2011-09-22       Impact factor: 1.704

6.  Determination of the Plasmodium vivax schizont stage proteome.

Authors:  Wanlapa Roobsoong; Sittiruk Roytrakul; Jetsumon Sattabongkot; Jianyong Li; Rachanee Udomsangpetch; Liwang Cui
Journal:  J Proteomics       Date:  2011-04-13       Impact factor: 4.044

Review 7.  Medical genetics in South Africa.

Authors:  T Jenkins
Journal:  J Med Genet       Date:  1990-12       Impact factor: 6.318

8.  Genetic and environmental influences on risk of death due to infections assessed in Danish twins, 1943-2001.

Authors:  Niels Obel; Kaare Christensen; Inge Petersen; Thorkild I A Sørensen; Axel Skytthe
Journal:  Am J Epidemiol       Date:  2010-04-07       Impact factor: 4.897

Review 9.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

10.  Characterisation of PfRON6, a Plasmodium falciparum rhoptry neck protein with a novel cysteine-rich domain.

Authors:  Nicholas I Proellocks; Lev M Kats; David A Sheffield; Eric Hanssen; Casilda G Black; Karena L Waller; Ross L Coppel
Journal:  Int J Parasitol       Date:  2008-11-27       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.